Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125080
Status:
RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-30
Brief Title:
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer UTILIZABLE Single-arm Prospective Open Clinical Study
Sponsor:
Huihua Xiong
Organization:
Tongji Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-30
First Submit QC Date:
November 5 2023
Study First Post Date:
2023-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-05
Last Update Post Date:
2023-11-09
Last Update Post Date Type:
ACTUAL